top of page

HQtest Health News: Surge in Chikungunya Fever Across Asia and Africa   August 3, 2025

Recent weeks have seen a dramatic uptick in chikungunya fever cases, with thousands of confirmed infections in China’s Guangdong province. Beyond southern China, outbreaks are rippling through Thailand, Malaysia, Cambodia, Vietnam, Laos, Myanmar, and other Asian nations, while several African countries continue to report sustained transmission.

Background and Latest Developments

Chikungunya fever is caused by the chikungunya virus, which is transmitted to humans primarily through bites from infected Aedes mosquitoes—most notably Aedes aegypti and Aedes albopictus. First identified in Tanzania in the 1950s, the name “chikungunya” derives from a Makonde word meaning “that which bends up,” referencing the severe joint pain that forces patients into a stooped posture.

In Guangdong alone, health authorities have logged over 4,800 confirmed cases within the past month. Thailand’s Ministry of Public Health reports similar surges, particularly in Bangkok and surrounding provinces. Neighboring countries across Southeast Asia, including:

  • Malaysia

  • Cambodia

  • Vietnam

  • Laos

  • Myanmar

  • Indonesia

have all documented growing clusters of infection. Concurrently, several African nations—including Kenya, Nigeria, and the Democratic Republic of Congo—are grappling with ongoing outbreaks, underscoring the virus’s persistent global threat.

Clinical Presentation

Patients typically experience:

  • High fever (often 39–40°C)

  • Sudden, debilitating joint pain affecting wrists, ankles, and small joints of the hands and feet

  • Diffuse skin rash

  • Myalgia and severe headache

  • Nausea, vomiting, and occasionally conjunctivitis

Symptoms emerge after an incubation period of 3–7 days (up to 12 days in some cases). While mortality remains low, certain populations—infants, elderly adults, and individuals with underlying health conditions—face a higher risk of complications, including chronic arthralgia lasting months or even years.

Diagnosis and Treatment

There is currently no specific antiviral therapy or licensed vaccine for chikungunya virus infection. Diagnosis relies on:

  • Serological testing for chikungunya-specific IgM and IgG antibodies

  • Reverse-transcription polymerase chain reaction (RT-PCR) to detect viral RNA

Treatment is entirely supportive and focuses on alleviating pain and fever:

  • Analgesics such as acetaminophen or non-steroidal anti-inflammatory drugs

  • Adequate hydration and rest

  • Use of cold compresses to reduce joint swelling

Prevention and Travel Advisory

Given the absence of a vaccine, prevention revolves around minimizing mosquito exposure. Public health recommendations include:

  • Applying insect repellents containing DEET or picaridin on exposed skin

  • Wearing long-sleeved clothing and long pants, especially during dawn and dusk

  • Installing and maintaining window and door screens

  • Eliminating standing water around homes (flower pots, gutters, discarded tires)

Health authorities strongly advise against nonessential travel to regions with active chikungunya transmission. Travelers returning from affected areas should monitor for symptoms for up to 12 days and seek immediate medical attention if fever or joint pain develops.

HQtest Pandemic Alert: American Travelers Urged to Exercise Caution in Taiwan Amid COVID-19 Surge
May 28, 2025

Taiwan, once widely recognized as a model for pandemic control during the early stages of COVID-19, is now experiencing an alarming surge in cases due to the spread of a mutated strain of the virus. Authorities at Taiwan’s Ministry of Health have warned that the number of COVID-19 patients could reach 200,000 by the end of next month.

On the 28th, Taiwanese media outlets—including the China Times and United Daily News—reported that a senior official from the Taiwan Centers for Disease Control, Lu Yi-chuan, stated that between the 18th and 24th of this month, emergency room visits related to COVID-19 exceeded 40,000 cases. This dramatic increase has led health experts to advise American travelers to exercise heightened caution when planning trips to Taiwan.

Officials continue to monitor the situation closely and urge visitors to stay informed about the latest travel advisories and public health guidelines to minimize potential exposure. Further updates on this evolving crisis are expected as local authorities work to contain the outbreak and safeguard public health.

In related developments, experts advocate for travelers to consider alternative destinations until the outbreak stabilizes, and remind the public to adhere to all preventive measures.

HQtest Travel Safety News: COVID-19 Resurgence in Thailand and China – What You Need to Know      May 21, 2025 

In recent weeks, health authorities have observed a renewed uptick in COVID-19 cases in parts of Asia, particularly in Thailand and China. This resurgence, which some experts attribute to a combination of waning immunity and increasing social interactions, means that travelers and locals must exercise extra caution.

 

The Situation in Thailand

Thailand, a destination known for its vibrant culture and bustling festivals, has experienced surges following high social activity—events like the traditional Songkran festival have historically been linked to accelerated virus transmission. Recent outbreaks indicate that clusters of infections following such public gatherings are again making headlines. The risks remain significant, whether it’s the result of a temporary dip in booster vaccinations or simply the natural ebb and flow of virus transmission. For anyone planning to visit or currently in Thailand, maintaining vigilance by following local health guidelines is essential. This includes wearing protective masks, sanitizing frequently, and staying aware of any travel advisories or updates from local authorities.

 

What’s Happening in China

China, too, is facing a similar challenge as COVID-19 cases begin to climb. Health experts point to rising test positivity rates and increasing community transmission as key signals of a new wave. This surge does not necessarily imply that all infections are severe—most cases may still be mild—but even a nominal rise in numbers can place added pressure on the healthcare system. The resurgence here is a reminder that even if large-scale public health interventions had previously brought the situation under control, continuous vigilance remains necessary. Travelers heading to or residing within China should ensure that their vaccination status is current, and they should be prepared for the possibility of encountering disruptions if further measures are implemented.

 

Travel Safety Recommendations

Given these developments, the guidance for travelers is clear and multifaceted:

- Stay Informed: Regularly check both international and local travel advisories. Reliable news outlets and government websites will post the latest updates on case numbers and any imposed measures.

- Practice Rigorous Hygiene: Consistent hand-washing, use of hand sanitizers, and wearing masks in crowded or enclosed spaces can drastically reduce risk. Vaccination and Boosters: Ensure that you are fully vaccinated and, if recommended, have received your booster dose. This step is critical, especially when visiting areas experiencing a rise in COVID-19 cases.

- Be Prepared for Changes: In regions where cases are climbing, authorities might reintroduce or tighten health protocols. It’s wise to have a flexible travel plan and the necessary resources (such as extra masks or rapid tests) on hand.

 

Why This Matters

The rise in cases serves as a stark reminder that although we have learned much about managing and mitigating COVID-19 over the past few years, the virus can still resurface. For travelers eager to explore new destinations or return to familiar favorites, these developments underscore the importance of balancing enthusiasm with caution. Adopting a proactive approach to health and safety not only protects you and your loved ones but also supports community efforts to curb the spread.

 

As the situation continues to evolve, keeping abreast of the latest information will be key to making informed decisions about your travels. Whether you are planning a vacation or a business trip, consider the current risk levels, evaluate your personal health situation, and be ready to adjust your plans if necessary.

NEWS

Comparing COVID-19 Vaccines 

Healing Quotient Scores of COVID-19 Vaccines According to Gender & Age

June 17, 2021  Updated 7:37 ET

Overall Healing Quotient of COVID-19 Vaccines

The overall Healing Quotient score of Pfizer vaccine is 140.  HQ score of Moderna is 125. AstraZeneca's HQ score is 90. Janssen's HQ score is 80.

Web_overall.jpg

Healing Quotient of Children's COVID-19 Vaccine 

Pfizer is now the only available Corona vaccine for children. Pfizer vaccine's HQ score for Children is 149.

Web_children.jpg

Healing Quotient of Female Adults'

COVID-19 Vaccines

The Healing Quotient score of Pfizer vaccine for female adults is 140. Moderna's HQ score is 125. AstraZeneca's HQ score is 90. Janssen's HQ score is 40.

Web_female.jpg

Healing Quotient of Older Adults'

COVID-19 vaccines

The Healing Quotient score of Pfizer COVID Vaccine for older adults is 140. Moderna's HQ score is 115. AstraZeneca performs well for old people with its Healing Quotient score 110. Janssen's HQ score is 80.

Web_older.jpg

Follow  HQTEST :

Fax : +82-2786-8589

Tel : +82-2786-8588

HQtest: Mapping a Safer World—The Future of News Services.

 

All Rights Reserved 

bottom of page